PIMREG and lung disorder: Our previous work identified CatS as a potential key mediator of early CF lung disease pathogenesis, and in vivo prophylactic targeting of CatS from birth resulted in significant reductions in neutrophilia, mucus obstruction, and lung remodelling in juvenile βENaC-Tg mice [18, 27].